masterThesis
Caracterización fibrilación auricular y nuevos anticoagulantes orales en urgencias - Fundación Santa Fe de Bogotá
Fecha
2017Autor
Sánchez Ayala, Brian Ingerman
Pimienta Neira, Fernando José
Institución
Resumen
Introduction: In recent years new oral anticoagulants are available for atrial fibrillation. In Colombia, the usage has become more frequent since 2013. This paper aims to characterize patients with nonvalvular atrial fibrillation in the era of new oral anticoagulantsMethodology: The electronic medical records were reviewed for patients who consulted the emergency department of the Santa Fe University Hospital in Bogotá. Specifically, patients with a primary or secondary diagnosis of atrial fibrillation between January 2013 and March 2015. Results: The prevalence of atrial fibrillation was 0. 29%. 229 patients were analyzed of which 54. 59% were men. 75. 1% were over 65 and those over 80 represented 41% of the population size. Warfarin was the most commonly used oral anticoagulant followed by dabigatran, rivaroxaban and apixaban. There were only 4 cases of major bleeding in anticoagulated patients; 2 with warfarin and 2 with dabigatran. 4 anticoagulated patients had a new ischemic stroke, 1 with warfarin, 1 with dabigatran and 2 with rivaroxaban. Discussion: In Colombia, the use of new anticoagulants is limited due to health care regulations. More similar or concurrent studies are required to be able to have enough data to support the use of these drugs in the country, without the need to extrapolate data from other sources.